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161 
CHARITY STARTS IN THE WOMB:  
NEW RESEARCH SHOULD ALLOW HEALTHY 
EMBRYOS AND FEDERALLY FUNDED STEM 
CELL RESEARCH TO COEXIST 
I. INTRODUCTION 
Monitoring stem cell research can be a bit like watching Niagara 
Falls. Not only do scientific reports pour forth daily, as they do in 
many other areas of research, but a kind of mist rises up [from] the 
torrent of news flashes and editorials, making it difficult to separate 
knowledge from opinion and hope from hype.1  
Many believe that stem cells hold the potential for curing a myriad of 
debilitating diseases.2 According to the President’s Council on Bioethics, 
if stem cells’ “healing powers could be harnessed, the medical benefits for 
humankind would be immense, perhaps ushering in an era of truly 
regenerative medicine.”3 However, stem cell research has been a hotly 
debated political issue since stem cells were first discovered in 1998.4 The 
ethical issues embedded in stem cell research, which fuel the political 
debate, stem from Roe v. Wade5 and grow more complex as the science 
develops.6 
 
 
 1. PRESIDENT’S COUNCIL ON BIOETHICS, MONITORING STEM CELL RESEARCH 15 (pre-
publication ed. 2004) [hereinafter MONITORING]. President Bush created the President’s Council on 
Bioethics on November 28, 2001, “to advise the President on bioethical issues related to advances in 
biomedical science and technology.” Id. at xvii. 
 2. See MONITORING, supra note 1, at 3. The diseases that stem cell research could affect include 
“juvenile diabetes, Parkinson’s disease, Alzheimer’s disease, spinal cord injuries, heart disease, and 
amyotrophic lateral sclerosis. These terrible diseases shorten life, limit activity (often severely), and 
cause great suffering both for the afflicted and their families.” PRESIDENT’S COUNCIL ON BIOETHICS, 
HUMAN CLONING AND HUMAN DIGNITY 145 (2002). 
 3. MONITORING, supra note 1, at 3. 
 4. Id. at 26. 
 5. Id. at 23. When the Supreme Court legalized abortion in Roe v. Wade, 410 U.S. 113 (1973), 
one concern was how the aborted fetuses might be used for research purposes. MONITORING, supra 
note 1, at 23. The following year, this concern led to a congressional moratorium on federal funding 
for “using human fetuses or living embryos.” Id. 
 6. See Laurie Zoloth, Freedoms, Duties, and Limits: The Ethics of Research in Human Stem 
Cells, in GOD AND THE EMBRYO: RELIGIOUS VOICES ON STEM CELLS AND CLONING 141, 141–42 
(Brent Waters & Ronald Cole-Turner eds., 2003) (“In fact, stem cell research, a technology barely out 
of the box, is one of the most fervently debated ethical issues of our day, the subject taken up by the 
United Nations, fourteen international and two American bioethics commissions, the U.S. Senate and 
House, and two administrations, not to mention nearly every major religious organization and patient 
care advocacy group.”). 
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There are three main methods of deriving stem cells, each believed by 
the scientific community to hold potential for medical benefit, and each 
with unique ethical issues.7 The most promising method to date is 
embryonic stem cell research,8 which has heretofore required the embryo’s 
destruction.9 Because the embryo’s moral status ranges from nonexistent 
to that of a fully developed human being,10 the embryo’s destruction is the 
source of most of the debate surrounding embryonic stem cell research.11 
This harm to the embryo prevents embryonic stem cell research from 
receiving federal funding, which is categorically denied for “research in 
which a human embryo or embryos are destroyed, discarded, or knowingly 
subjected to risk of injury or death.”12 President Bush, in his August 9, 
2001 speech, did grant federal funding eligibility to embryonic stem cell 
lines13 which had already been established with private funds and qualified 
under specific guidelines,14 but these stem cell lines are limited both in 
number15 and potential.16 
In August of 2006, Dr. Robert Lanza published a scientific study in 
Nature demonstrating how stem cell lines could be developed for research 
by removing a single cell from a developing embryo.17 The research 
 
 
 7. See infra notes 29–37 and accompanying text. 
 8. Ronald B. Miller, Twenty-Third Annual Health Law Symposium “Contemporary Issues in 
Children’s Health”: Ethical Issues in Stem Cell Research, Therapy, and Public Policy, 26 WHITTIER 
L. REV. 845, 862 (2005) (“‘No non-embryonic sources of stem cells . . . have been shown to have 
anything like the potential to lead to viable treatments for such diseases as juvenile diabetes, 
Parkinson’s and spinal cord injury that stem cells derived from very early embryos do.’” (quoting Ruth 
R. Faden & John D. Gearhart, Facts on Stem Cells, WASH. POST, Aug. 23, 2004, at A15)). 
 9. MONITORING, supra note 1, at 8. 
 10. See Miller, infra note 120 and accompanying text. 
 11. Nicholas Wade, In New Method for Stem Cells, Viable Embryos, N.Y. TIMES, Aug. 24, 2006, 
at A1 (noting that the destruction of the embryo is “a principal objection of those who oppose the 
research”). 
 12. Balanced Budget Downpayment Act, Pub. L. No. 104-99, §128, 110 Stat. 26, 128 (1996); see 
also MONITORING, supra note 1, at 26 n.8 (explaining the Dickey Amendment and its subsequent 
codifications). 
 13. See infra notes 38–41 and accompanying text. 
 14. See President George W. Bush, Remarks by President George W. Bush on Stem Cell 
Research (Aug. 9, 2001), reprinted in PRESIDENT’S COUNCIL ON BIOETHICS, MONITORING STEM CELL 
RESEARCH app. B (pre-publication ed. 2004). 
 15. See Joanna K. Sax, The States “Race” with the Federal Government for Stem Cell Research, 
15 ANNALS HEALTH L. 1, 17 (2006) (noting that seventy-eight stem cell lines are eligible for federal 
funding and that eleven of those are currently available for research use). 
 16. Miller, supra note 8, at 858 (“A serious problem for stem cell research and therapy limited to 
use of the cell lines produced prior to the August, 9, 2001 pronouncement by President George W. 
Bush, is that all were grown on a medium containing mouse feeder cells raising concern of cross-
species infection transfer and perhaps immunologic concerns.”).  
 17. Robert Lanza et al., Human Embryonic Stem Cell Lines Derived from Single Blastomeres, 
NATURE, Nov. 23, 2006, 444 at 481–85; see also Karen Kaplan, Stem Cell Advance Spares Embryos: 
Bush Officials Say It’s Too Soon to Rule on the Process, Which May Ease Ethical Concerns. Critics 
https://openscholarship.wustl.edu/law_lawreview/vol85/iss1/4
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establishes a method for embryonic stem cell research that does not result 
in the embryo’s destruction.18 Dr. Lanza’s research thus overcomes the 
major moral dilemma of previously used techniques19 and satisfies the 
requirement of the current federal funding restrictions.20 While private 
funding for research is available,21 public and private motives can differ 
considerably,22 and “[h]istory has shown that research in this country 
advances at a faster pace with federal funding.”23 The absence of federal 
funding impedes the growth of what may prove to be the greatest medical 
advancement to date.24 Dr. Lanza’s new method of embryonic stem cell 
research should therefore receive federal funding. 
In Part II, I will begin by tracing the progress of stem cell research 
from the discovery of stem cells through Dr. Lanza’s innovative study. I 
will then identify legislative materials—such as the Dickey Amendment—
that restrict federal funding for stem cell research, subsequent legislative 
proposals to alter such restrictions, and the executive policies of Presidents 
Bill Clinton and George W. Bush concerning federal funding for stem cell 
research. Third, I will discuss key religious and moral arguments both for 
and against embryonic stem cell research. In Part III, I will discuss the 
preexisting moral dilemmas that Dr. Lanza’s technique leaves unresolved, 
new moral dilemmas it creates, and the pros and cons of granting federal 
funding for stem cell research using Dr. Lanza’s technique. In Part IV, I 
will propose that Dr. Lanza’s technique is an ideal middle ground that 
allows federal funding for embryonic stem cell research by alleviating the 
 
 
Say There’s No Certainty It Doesn’t Cause Injury., L.A. TIMES, Aug. 24, 2006, at A1. 
 18. Lanza, supra note 17, at 481. 
 19. Rick Weiss, Senators Denounce Scientist’s Stem Cell Claims; Confusion Over Harm to 
Embryos in Study at Issue, WASH. POST, Sept. 7, 2006, at A4 (“Embryonic stem cells are prized for 
their medical and research potential, and until Lanza’s experiment they had been grown only by 
methods that necessitated the destruction of an embryo.”). 
 20. See supra Part III.A. See also infra note 68 (citing current legislative restrictions on federal 
funding). 
 21. LAURA BLACK, THE STEM CELL DEBATE: THE ETHICS AND SCIENCE BEHIND THE RESEARCH 
75 (2006). 
 22. Suzanne Kadereit & Pamela J. Hines, An Overview of Stem Cell Research, 39 NEW ENG. L. 
REV. 607, 620 (2005) (“Companies have different priorities than public-sector government-supported 
research, however, which affects the directions the companies choose to research and whether the 
results will be publicly available.”). 
 23. Id. 
 24. Miller, supra note 8, at 857–58 (“Perhaps the biggest ethical issue regarding stem cell 
research is the potential missed opportunity. If restrictions on research preclude, or even just delay, 
investigation that might lead to cures, or even just amelioration, of diseases thought to be amenable to 
the promise of stem cell therapy.”); id. at 849 (“The potential of stem cell research to result in 
remarkable therapies is a potential boon to mankind.”). 
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moral concerns raised by federal funding restrictions. Dr. Lanza’s 
technique should therefore receive federal funding. 
II. BACKGROUND 
A. Stem Cells 
The first reported isolation of human embryonic stem cells occurred at 
the University of Wisconsin in 1998.25 A stem cell is defined by its 
potential to reproduce indefinitely and by its ability to differentiate itself 
into different types of cells.26 It is precisely these abilities which make 
stem cells ideal for medical research purposes,27 and scientists anticipate 
extraordinary results.28 
Stem cells can derive from three sources: embryonic stem cells, 
embryonic germ cells, and adult stem cells. Embryonic stem cells are 
typically taken from an embryo five to nine days after it has been fertilized 
through in vitro fertilization, when the embryo consists of approximately 
200 cells.29 The inner cells—which typically develop into the body of the 
individual—are harvested, resulting in the destruction of the embryo.30 
Embryonic germ cells are acquired from five- to nine-week-old aborted 
fetuses that have been donated for research.31 Both embryonic stem cells 
and embryonic germ cells possess the extraordinary abilities to regenerate 
and to differentiate into any type of cell in the human body.32 “Because 
 
 
 25. MONITORING, supra note 1, at 26. 
 26. Id. at 2 (“Themselves relatively undifferentiated and unspecialized, they can and do give rise 
to the differentiated and specialized cells of the body (for example, liver cells, kidney cells, brain 
cells).”). 
 27. See Kadereit & Hines, supra note 22, at 617 (“Embryonic stem cells are so attractive for 
research because they grow well in culture and retain the property of pluripotency during extended 
culture growth. Thus, after prolonged culture periods, embryonic stem cells can still produce a wide 
array of the cells of the body in culture. Embryonic stem cells provide, therefore, an unlimited supply 
of stem cells and specialized cells for meaningful experiments.”). 
 28. Miller, supra note 8, at 849 (“Stem cell research should yield at least six benefits: (1) 
Allowing an understanding of disease mechanisms and thus; (2) the design of effective therapy with 
drugs targeted at basic mechanisms; (3) the repair or replacement of damaged tissues or organs; (4) 
growing organs in vitro or in vivo to lessen dependence on cadaveric and live donors of organs which 
are in such short supply that many recipients wait two to five years for a transplant (and many 
unfortunately die waiting); (5) avoiding immunologic rejection (which at least presently requires 
somatic cell nuclear transfer (SNCT) from the patient to an egg whose own nucleus was removed; and, 
(6) it appears that stem cell therapy for spinal cord injury minimizes scarring and releases growth 
factors which stimulate neural repair.”). 
 29. MONITORING, supra note 1, at 8. 
 30. Id. 
 31. See id. at 9. 
 32. Id. 
https://openscholarship.wustl.edu/law_lawreview/vol85/iss1/4
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they are so flexible, it also seems likely that they could be used to produce 
cell preparations that could then be transplanted . . . to repopulate a part of 
the body such as the pancreas or spinal cord that has lost function due to 
disease or injury.”33 Adult stem cells are derived from “various tissues in 
children as well as adults.”34 While some believe that adult stem cells 
could potentially be as flexible as embryonic stem and germ cells,35 adult 
stem cells are already partially differentiated36 and “biologists are 
unanimous that even the most potent adult stem cells cannot approach the 
therapeutic power of embryonic stem cells.”37 
Stem cells are only of medical and scientific value if they can be 
studied, which first requires their isolation and culture.38 Stem cells are 
placed in a dish along with feeder cells, which provide the nutrients the 
stem cells need to swiftly multiply.39 The stem cells in the original dish 
may then be divided and distributed to other dishes to continue culturing.40 
After the cells have been cultured for six to twelve months, all cells 
resulting from the original embryo are referred to as one stem cell line.41 
B. Dr. Lanza’s Research 
About fifty fertility clinics, most in the United States, use a technique 
known as preimplantation genetic diagnosis (PGD), first used in 1989.42 
About three days after an embryo’s in vitro fertilization43—when the 
embryo consists of merely eight cells called blastomeres44—one of these 
cells is removed45 and tested for genetic markers associated with more 
 
 
 33. Id. 
 34. Id. at 10. 
 35. Id. 
 36. Id. 
 37. CHRISTOPHER THOMAS SCOTT, STEM CELL NOW: FROM THE EXPERIMENT THAT SHOOK THE 
WORLD TO THE NEW POLITICS OF LIFE 89 (2006). See also TONEY ALLMAN, STEM CELLS 51 (2006) 
(“Except for the hematopoietic stem cells from bone marrow, adult stem cells are difficult for 
scientists to use in medical therapies. Adult stem cells are hard to identify and isolate, do not grow 
easily in the laboratory, and often remain inactive instead of turning on to make new cells.”). 
 38. MONITORING, supra note 1, at 3. 
 39. BLACK, supra note 21, at 45. 
 40. Id. 
 41. Id. 
 42. PRESIDENT’S COUNCIL ON BIOETHICS, REPRODUCTION & RESPONSIBILITY: THE 
REGULATION OF NEW BIOTECHNOLOGIES 90 (2004). 
 43. Id. at 91. 
 44. Blastomere, in THE AMERICAN HERITAGE DICTIONARY OF THE ENGLISH LANGUAGE (4th ed. 
2006), available at http://dictionary.reference.com/browse/blastomere (“Any of the cells resulting 
from the cleavage of a fertilized ovum during early embryonic development.”). 
 45. Wade, supra note 11. 
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than one hundred diseases.46 These diseases include Lesch Nyhan 
syndrome, hemophilia, mental retardation, Down syndrome, Turner 
syndrome, cystic fibrosis, Tay-Sachs disease, and even Alzheimer 
disease.47 If no markers are identified, the seven-cell embryo is 
implanted.48 While not all clinics practice PGD, estimates suggest that 
between 1,000 and 2,000 children49 have been created through this 
technique.50  
Dr. Robert Lanza, medical director of Advanced Medical Technology, 
was the senior author of a study published in the scientific journal Nature 
in August of 2006.51 Dr. Lanza demonstrated through his research that the 
blastomeres removed for PGD could also be used to derive stem cell lines 
without interfering with the clinic’s test.52 Using this method, no embryos 
are destroyed,53 and the ethical considerations are limited to the risk posed 
to the developing embryo by removing a cell,54 or blastomere. While Dr. 
Lanza’s research did result in the destruction of all embryos,55 his intent 
was to demonstrate that a single blastomere could develop into a stem cell 
line; years of PGD had already established the ability of an embryo to 
survive the removal of a blastomere.56 An apparent goal of the research 
 
 
 46. REPRODUCTION & RESPONSIBILITY, supra note 42, at 90. 
 47. Id. 
 48. Wade, supra note 11. 
 49. REPRODUCTION & RESPONSIBILITY, supra note 42, at 90 (quoting Genetics and Public Policy 
Center, Preimplantation Genetic Diagnosis: A Discussion of Challenges, Concerns, and Preliminary 
Policy Options Related to the Genetic Testing of Human Embryos, Washington, D.C. (2004)). 
 50. Wade, supra note 11 (“Dr. Andrew La Barbera, scientific director of the American Society 
for Reproductive Medicine, said that more than 2,000 babies had been born in the United States after a 
preimplantation genetic diagnosis.”). 
 51. Kaplan, supra note 17. For the published study, see Lanza, supra note 17. 
 52. “By growing the single blastomere overnight, the resulting cells could be used for both 
genetic testing and stem cell derivation without affecting the clinical outcome of the procedure.” 
Lanza, supra note 17, at 481. 
 53. Alison Abbott, ‘Ethical’ Stem-Cell Paper Under Attack: Study in Nature Berated for Lack of 
Clarity, NATURE, Sept. 6, 2006, http://www.nature.com/news/2006/060904/full/443012a.html 
(explaining that Dr. Lanza carried out his research to demonstrate the viability of such method—which 
allows an embryo to continue developing after the removal of a single cell for testing—but noting that 
he did not actually employ this method in his research). 
 54. Id. (“Norio Nakatsuji of Kyoto University, who derived Japan’s only human embryonic 
stem-cell lines, points out that the process poses a small risk to the baby.”). 
 55. Rick Weiss, Critic Alleges Deceit in Study on Stem Cells: Report’s Basic Facts Are 
Unchallenged, WASH. POST, Aug. 26, 2006, at A2 (“In the experiments, the scientists took as many 
cells as they could from each embryo, destroying them in the process, to make the most of the embryos 
donated for their study.”); see also Abbott, supra note 53 (“Lanza says he never intended to say more 
than that he had proved a principle, and that . . . the established procedure of pre-implantation genetic 
diagnosis . . . has already shown that embryos from which a blastomere has been removed survive. 
‘We knew that, so we took multiple cells from each embryo so as not to be wasteful,’ he says.”). 
 56. Weiss, supra note 55. 
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was, in fact, to create a technique which would allow federal funding for 
embryonic stem cell research.57 
C. Legislation 
The current debate over federal funding for stem cell research stretches 
back to 1973,58 twenty-five years before embryonic stem cells were first 
isolated.59 After the Supreme Court handed down its decision in Roe v. 
Wade,60 Congress began to consider how science might use, or possibly 
abuse, aborted fetuses.61 Endorsing the policy of the Department of 
Health, Education and Welfare,62 Congress passed a law in 1974 
temporarily denying any “federal funding for clinical research using ‘a 
living human fetus, before or after the induced abortion of such fetus, 
unless such research is done for the purpose of assuring the survival of 
such fetus.’”63 The blanket ban was lifted the following year, when the 
regulation of federal funding for human embryo research was returned to 
the Department of Health, Education and Welfare.64 The Department 
never approved funding,65 and the choice was taken out of its hands in 
1996 when Representative Jay Dickey proposed a ban on federal funding 
for research that could harm human embryos or that created human 
embryos specifically for research purposes.66 The “Dickey Amendment,” 
“attached to the Health and Human Services appropriations bill each year 
 
 
 57. Abbott, supra note 53 (“[Lanza] hopes the methodology will provide a source of stem cells 
compatible with US law, which prohibits public funding of research into new human embryonic cell 
lines derived at the expense of embryos.”). 
 58. MONITORING, supra note 1, at 23. 
 59. Id. at 26. 
 60. 410 U.S. 113 (1973). In Roe v. Wade, the Supreme Court held that anti-abortion laws violate 
a woman’s right to privacy under the Fourteenth Amendment. 
 61. MONITORING, supra note 1, at 23. 
 62. Id. (After Roe v. Wade, the Department of Health, Education and Welfare “initiated a 
moratorium on any potential DHEW sponsorship or funding of research using human fetuses or living 
embryos.”). The Department of Health, Education and Welfare was the forerunner of today’s 
Department of Health and Human Services. Id. 
 63. Id. 
 64. In 1975, the task of providing advice on federal funding standards for human embryo 
research fell to the newly created Ethics Advisory Board created within the Department of Health, 
Education and Welfare. While the Board determined in 1979 that research involving human embryos 
less than fourteen days old which had been donated by married couples was ethical, the Board did not 
offer an opinion as to what, if any, federal funding such research should receive. See id. at 23–24. 
 65. The charter for the Ethics Advisory Board, through which funding requests for embryonic 
research had to go, lapsed in 1980, in effect creating another moratorium. Congress nulled the Board’s 
involvement in 1993, passing such funding decisions to the National Institutes of Health (NIH). 
MONITORING, supra note 1, at 24. The NIH failed to approve any funding before the passage of the 
Dickey Amendment. Id. at 25. 
 66. Id. at 25. 
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since 1996,”67 specifically forbids federal funding for “research in which a 
human embryo or embryos are destroyed, discarded, or knowingly 
subjected to risk of injury or death . . . .”68 Embryos for which federal 
funding is forbidden include those “derived by fertilization, 
parthenogenesis, cloning, or any other means from one or more human 
gametes or human diploid cells.”69 However, the amendment in no way 
affects private funding of such research.70 The Dickey Amendment 
“effectively prohibits the use of federal funds to support any research that 
destroys human embryos or puts them at serious risk of destruction,”71 but, 
according to a generally accepted and presidentially endorsed72 
interpretation proposed by the Department of Health and Human 
Services,73 the federal government might nevertheless fund embryonic 
stem cell research after the embryo has been destroyed.74 Still, some argue 
 
 
 67. Id. 
 68. Balanced Budget Downpayment Act, Pub. L. No. 104-99, §128, 110 Stat. 26, 128 (1996). 
The most modern version of the amendment in its entirety reads:  
 (a) None of the funds made available in this Act may be used for— 
 (1) the creation of a human embryo or embryos for research purposes; or  
 (2) research in which a human embryo or embryos are destroyed, discarded, or 
knowingly subjected to risk of injury or death greater than that allowed for research on 
fetuses in utero under 45 CFR 46.204(b) and section 498(b) of the Public Health Service Act 
(42 U.S.C. 289g(b)). 
 (b) For purposes of this section, the term “human embryo or embryos” includes any 
organism, not protected as a human subject under 45 CFR 46 as of the date of the enactment 
of this Act, that is derived by fertilization, parthenogenesis, cloning, or any other means from 
one or more human gametes or human diploid cells.  
Department of Health and Human Services Appropriations Act 2006, Pub. L. No. 109-149, §509, 119 
Stat. 2833, 2280 (2005). 45 C.F.R. § 46.204, to which the Dickey Amendment refers, reads in 
pertinent parts as follows: 
Pregnant women or fetuses may be involved in research if all of the following conditions are 
met: 
. . . (b) The risk to the fetus is caused solely by interventions or procedures that hold out the 
prospect of direct benefit for the woman or the fetus; or, if there is no such prospect of 
benefit, the risk to the fetus is not greater than minimal and the purpose of the research is the 
development of important biomedical knowledge which cannot be obtained by any other 
means. 
45 C.F.R. § 46.204 (2007). “(b) Risk standard for fetuses intended to be aborted and fetuses intended 
to be carried to term to be the same.” 42 U.S.C. § 289g (2006). 
 69. MONITORING, supra note 1, at 26 (quoting Balanced Budget Downpayment Act, I, Pub. L. 
No. 104-99, § 128, 110 Stat. 26, 128 (1996)). 
 70. Id. 
 71. Id. 
 72. Id. at 27 (noting that both President Clinton and President Bush have used this interpretation 
in forming related policies). 
 73. Id. (citing Memorandum from Harriet S. Rabb, Gen. Counsel of the Dept. of Health and 
Human Services, to Harold Varmus, Dir. of the Nat’l Institutes of Health (Jan. 15, 1999) (on file with 
the National Archives)). 
 74. By funding research that was made possible by the prior destruction of an embryo, as 
https://openscholarship.wustl.edu/law_lawreview/vol85/iss1/4
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that this interpretation violates the “spirit of the law.”75 Embryonic stem 
cells were not isolated until two years after the initial passage of the 
Dickey Amendment.76 
In May of 2005, four years after President George W. Bush announced 
a policy that declared future stem cell lines ineligible for federal funding,77 
the House of Representatives passed a bill to allow federal funding for 
research on certain types of stem cell lines.78 Under the Stem Cell 
Research Enhancement Act of 2005,79 stem cell lines derived from 
leftover and unneeded embryos from in vitro fertilization clinics would 
have been eligible for federal funding,80 “regardless of the date on which 
the stem cells were derived.”81 The bill was stalled in the Senate until late 
June of 2006,82 but the measure passed in July 2006 by a vote of sixty-
three to thirty-seven.83 As promised,84 President Bush vetoed the bill.85 
The two-thirds majority needed to override the veto was fifty-one votes 
shy in the House, with a vote of 235–193.86 Many other bills relating to 
the federal funding policy for embryonic stem cell research have been 
proposed and others are still pending, but none have passed both houses of 
Congress.87 
 
 
opposed to funding research that itself destroys the embryo, the Department argued that federal funds 
would not be going to research “‘in which’” human embryos were injured. Id. 
 75. Id. at 27 n.10 (“This case was made, for instance, in a letter authored by Rep. Jay Dickey and 
signed by seventy other members of Congress to DHHS Secretary Donna Shalala, February 11, 
1999.”). 
 76. Id. at 25–26. 
 77. Bush, supra note 14, at 184. President Bush stated that federal funding would be limited to 
those stem cell lines which had already been derived by the date of his speech: August 9, 2001. Id.  
 78. Senate Revives Bill to Finance Stem Cell Research, N.Y. TIMES, June 29, 2006, available at 
2006 WL 11316582.  
 79. Stem Cell Research Enhancement Act of 2005, H.R. 810, 109th Cong. (2005). 
 80. Id. 
 81. Id. Because the bill would have made federal funding available to stem cell lines without 
reference to the date of stem cell derivation, the bill would have gone against President Bush’s policy 
limiting federal funding to those lines derived before August 9, 2001. See infra note 92 and 
accompanying text. 
 82. Senate Revives Bill to Finance Stem Cell Research, supra note 78. Nancy Reagan is credited 
with helping the bill pass in the House and for pushing the bill through its stall in the Senate. In 2004, 
Former President Ronald Reagan succumbed to Alzheimer’s disease, the effects of which could one 
day be relieved or even alleviated through stem cell research. Id.  
 83. Carl Hulse, Senate Approves a Stem Cell Bill; Veto Is Expected, N.Y. TIMES, July 19, 2006, 
at A1. 
 84. Peter Baker, President Vows Veto On Stem Cell Research: Bipartisan Measure Seeks to Ease 
Curbs, WASH. POST, May 21, 2005, at A6. 
 85. Letter from George W. Bush, President of the U.S., to the House of Representatives (July 19, 
2006), available at http://www.whitehouse.gov/news/releases/2006/07/20060719-5.html. 
 86. Sheryl Gay Stolberg, First Bush Veto Maintains Limits on Stem Cell Use, N.Y. TIMES, July 
20, 2006, at A1. 
 87. See, e.g., Stem Cell Research Expansion Act, S. 362, 110th Cong. (2007) (proposing to allow 
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D. Effect of the Executive 
In contrast to the Bush administration, President Clinton endorsed 
embryonic stem cell funding under certain conditions. Under Clinton’s 
policy, the embryos were limited to those leftover from fertility 
procedures, and stem cells must have previously been harvested from 
these embryos with private funding.88 Donors must have consented to the 
embryo’s use for research, without enticement, but the embryo must not 
have been specifically created for that purpose.89 These guidelines were 
completed as Clinton’s second presidential term was coming to an end. 
The guidelines were therefore never implemented, and corresponding 
funding was never awarded.90  
President Bush stayed President Clinton’s policy when he took office 
in 2001.91 President Bush’s policy, which he announced in a speech on 
August 29, 2001,92 had the objective of utilizing stem cells that had 
already been harvested without encouraging further embryo destruction.93 
According to President Bush, “extracting the stem cell destroys the 
embryo, and thus destroys its potential for life.”94 Therefore, federal 
funding would only be granted to stem cell lines in which stem cells had 
already been removed, to the point of preventing the embryo’s further 
development, before 9:00 p.m. Eastern Time on August 9, 2001.95 
 
 
federal funding for stem cell lines derived before January 23, 2006, such that federal dollars would not 
fund the destruction of an embryo); Alternative Pluripotent Stem Cell Therapies Enhancement Act, S. 
2754, 109th Cong. (as passed by Senate, July 13, 2006) (proposing that federal funds be directed 
toward the “isolation, derivation, production, or testing” of non-embryonic sources of pluripotent stem 
cells); Stem Cell Replenishment Act of 2005, H.R. 162, 109th Cong. (2005) (proposing that stem cell 
lines be eligible for federal funding regardless of their dates of derivation, but in all other ways 
remaining subject to the current NIH guidelines). 
 88. National Institutes of Health Guidelines for Research Using Human Pluripotent Stem Cells, 
65 Fed. Reg. 51975 (Aug. 25, 2000), reprinted in PRESIDENT’S COUNCIL ON BIOETHICS, MONITORING 
STEM CELL RESEARCH app. D, at 191 (pre-publication ed. 2004) (“Studies utilizing pluripotent stem 
cells derived from human embryos may be conducted using NIH funds only if the cells were derived 
(without Federal funds) from human embryos that were created for the purposes of fertility treatment 
and were in excess of the clinical need of the individuals seeking such treatment.”). 
 89. Id. at 191–92. 
 90. MONITORING, supra note 1, at 28. 
 91. Id. 
 92. Bush, supra note 14, at 181. 
 93. MONITORING, supra note 1, at 28 and 34. 
 94. Bush, supra note 14, at 182. 
 95. Office of the Dir. of the Nat’l Institutes of Health, Notice of Criteria for Federal Funding of 
Research on Existing Human Embryonic Stem Cells and Establishment of NIH Human Embryonic 
Stem Cell Registry (Nov. 7, 2001), reprinted in PRESIDENT’S COUNCIL ON BIOETHICS, MONITORING 
STEM CELL RESEARCH app. C, at 187 (pre-publication ed. 2004). 
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President Bush estimated that over sixty existing stem cell lines would be 
eligible for this federal funding.96 
President Bush recognized the potential in the existing stem cell lines: 
they were “genetically diverse,” able to “regenerate themselves 
indefinitely,” and would enable “us to explore the promise and potential of 
stem cell research without crossing a fundamental moral line.”97 However, 
limiting federal funding to these stem cell lines has severe drawbacks. 
First, “the limited number of cell lines that the Bush administration 
approved for federally funded research is, at best, adequate only for basic 
research to determine the most promising avenues for further 
exploration.”98 According to the director for the National Institutes of 
Health, seventy-eight stem cell lines are eligible for federal funding.99 
However, “eligibility is not the same thing as availability.”100 The seventy-
eight eligible lines will not all become available for use,101 eighteen of 
them already having become permanently unavailable.102 As of September 
2003,103 only twelve lines were available to the scientific community,104 
 
 
 96. Bush, supra note 14, at 184 (“As a result of private research, more than 60 genetically 
diverse stem cell lines already exist . . . . I have concluded that we should allow federal funds to be 
used for research on these existing stem cell lines, where the life and death decision has already been 
made.”). 
 97. Id. 
 98. Richard M. Doerflinger, The Ethics and Policy of Embryonic Stem Cell Research: A Catholic 
Perspective, in STEM CELL RESEARCH: NEW FRONTIERS IN SCIENCE AND ETHICS 143, 150 (Nancy E. 
Snow ed., 2003). 
 99. Sax, supra note 15, at 17 (citing Stem Cell Research, Hearing Before Senate Appropriations 
Subcommittee on Labor: Health and Human Services, and Education, 108th Cong. (2003) (statement 
of Elias A. Zerhouni), available at http://olpa.od.nih.gov/hearings/108/session1/testimonies/ 
stemcell.asp). As of January 25, 2007, the number of eligible stem cell lines was still seventy-eight. 
Nat’l Institutes of Health, Information on Eligibility Criteria for Federal Funding of Research on 
Human Embryonic Stem Cells, http://stemcells.nih.gov/research/registry/eligibilitycriteria (last visited 
Jan. 25, 2007). 
 100. MONITORING, supra note 1, at 42. 
 101. See id. at 43 (“The process of establishing a human embryonic stem cell line, turning the 
originally extracted cells into stable cultured populations suitable for distribution to researchers, 
involves an often lengthy process of growth, characterization, quality control and assurance, 
development, and distribution. In addition, the process of making lines available to federally funded 
researchers involves negotiating a contractual agreement (a ‘materials transfer agreement’) with the 
companies or institutions owning the cell lines, establishing guidelines for payment, intellectual 
property rights over resulting techniques or treatments, and other essential legal assurances between 
the provider and the recipient.”). An additional hurdle to availability is that these lines can change over 
time, and “[c]hromosomal alterations have already been observed in a few of the approved cell lines.” 
Kadereit & Hines, supra note 22, at 620.  
 102. Nat’l Institutes of Health, Information on Eligibility Criteria for Federal Funding of Research 
on Human Embryonic Stem Cells, supra note 99. Reasons for the stem cell lines’ unavailability 
include “the cells failed to expand into undifferentiated cell cultures,” “cell line no longer eligible for 
federal funding,” and the cell line’s withdrawal by its donor. Id. 
 103. MONITORING, supra note 1, at 42. 
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and by January 2007, this number had risen to just twenty-one stem cell 
lines worldwide that are both eligible for federal funding and available for 
use.105 The number of available lines is important because many more will 
be needed for clinical applications “in order to provide an immunological 
match for as many patients as possible.”106 Second, all seventy-eight of the 
eligible lines were grown using mouse feeder cells, “raising concern of 
cross-species infection transfer and perhaps immunologic concerns,”107 
and further limiting the viability of the lines currently eligible for federal 
funding. 
In July of 2006, President Bush vetoed a bill that would have annulled 
his federal funding policy for embryonic stem cell research.108 It was the 
first veto of his presidency.109 The Stem Cell Research Enhancement Act 
of 2005 would have allowed federal funding for stem cell lines derived 
from embryos that were created for in vitro fertilization but were no longer 
needed and would otherwise have been destroyed.110 
President Bush has also not endorsed Dr. Lanza’s new technique. A 
White House spokeswoman stated, “‘Any use of human embryos for 
research purposes raises serious ethical questions. This technique does not 
resolve those concerns.’”111 She later stated that President Bush would 
hold his opinion for further analysis of Dr. Lanza’s research.112 
 
 
 104. Id. at 43 (citing NIH Stem Cell Registry website at http://stemcells.nih.gov). 
 105. Nat’l Institutes of Health, Information on Eligibility Criteria for Federal Funding of Research 
on Human Embryonic Stem Cells, supra note 95. 
 106. Kadereit & Hines, supra note 22, at 621. Obtaining an immunological match between the 
stem cells and the recipient is important because the recipient’s body will otherwise identify the stem 
cells as “foreign” and attack and kill the cells. Studies show that embryonic stem cells could be 
capable of immune rejection just as whole organ transplants are currently. Organ transplant recipients 
must take immunosuppressive drugs, which carry significant side effects, for the rest of their lives in 
order to keep their bodies from rejecting the donor organs. Researchers hope to avoid the same fate for 
stem cell recipients by eliminating the immune rejection problem. MONITORING, supra note 1, at 131–
32.  
 107. Miller, supra note 8, at 858. See also Kadereit & Hines, supra note 22, at 620 (warning that 
use of the government-funded stem cell lines, which were cultured with mouse feeder cells, entails the 
risk of introducing murine viruses in humans—a potential cross-species contamination as was recently 
seen with SARS and avian flu). 
 108. Stolberg, supra note 86; see also supra note 85. 
 109. Stolberg, supra note 86. 
 110. Id.; see also supra notes 79–86 and accompanying text. 
 111. Wade, supra note 11 (quoting White House spokeswoman Emily Lawrimore). 
 112. Editorial, A Way Out?: Scientists Might Now Be Able to Harvest Stem Cells Without 
Harming Embryos, WASH. POST, Aug. 28, 2006, at A14. 
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E. Religious Arguments and Moral Concerns 
[I]n his new book on the embryo research debate, Professor Ronald 
Green—formerly vice-chair for ethics of the Human Embryo 
Research Panel at the National Institutes of Health (NIH)—writes 
that the Catholic bishops conference of the United States has been 
“the most active and effective center of opposition to all facets of 
human embryo research” and now to embryonic stem cell 
research.113  
Indeed, much of the opposition to and even some of the support for 
embryonic stem cell research derives from religious beliefs.114  
“The stem cell itself is not the turf to be won; rather, it is the moral 
status of the embryo from which the stem cell is derived.”115 The embryo’s 
moral status is central to the religious debate over embryonic stem cell 
research. At some point an embryo changes from a cluster of cells to a 
human being, but at what precise point in its development this change 
occurs is unclear.116 An embryo refers less to a specific being than it does 
to a “certain stage of development”117—a stage that precedes that of 
fetus,118 which precedes birth.119  
Although all agree the blastocyst is human and is living, some hold 
that this mass of thirty cells that is barely visible and only the size 
of the head of a pin, has no human form, has no nervous system, is 
 
 
 113. Doerflinger, supra note 98, at 143 (quoting RONALD GREEN, THE HUMAN EMBRYO 
RESEARCH DEBATES: BIOETHICS IN THE VORTEX OF CONTROVERSY 158 (2001)). 
 114. BLACK, supra note 21, at 89–92 (explaining that the Catholic and Jewish perspectives are 
perhaps the best represented in the media because their religious doctrines more clearly support one 
side of the debate where other religious doctrines leave the issue open to individual interpretation; 
explaining why the Catholic position opposes embryonic stem cell research and the Jewish position 
supports it). See also Ted Peters, The Stem Cell Controversy, in THE STEM CELL CONTROVERSY: 
DEBATING THE ISSUES 231, 232 (Michael Ruse & Christopher A. Pynes eds., 2d ed. 2006) (“[T]his is 
not merely a matter of science and public policy; it is a religious issue.”). 
 115. Ted Peters & Gaymon Bennett, A Plea for Beneficence: Reframing the Embryo Debate, in 
GOD AND THE EMBRYO, supra note 6, at 111, 112. 
 116. Ronald Cole-Turner, Principles and Politics: Beyond the Impasse over the Embryo, in GOD 
AND THE EMBRYO, supra note 6, at 88, 89–92 (discussing the difficulty in determining the moral status 
of a developing embryo and noting the difference between biological development and the 
development of the embryo’s moral status). 
 117. MONITORING, supra note 1, at 12. 
 118. Id. at 147 (presenting multiple “embryo” definitions, each with the embryo ceasing to exist 
when it becomes known as a fetus); see also BLACK, supra note 19, at 41 (noting that most scientists 
agree that the term human embryo “refers to a fertilized egg cell during the first two months of its 
development,” after which it is known as a fetus). 
 119. MONITORING, supra note 1, at 148. 
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not a person, has no soul, and thus need not be accorded the 
protection due to persons or ensouled beings. Others, however, 
believe that from the very moment of conception because the 
zygote-morula-blastocyst has the potential to become a child and 
later an adult, it has full moral status and must not be harmed or 
destroyed.120  
To kill a human being without justification is murder, but to destroy 
human tissue is innocent.121 The embryo’s moral status seems to range 
between that of human tissue and human being,122 leading some to err on 
the side of caution. For others, the potential benefit of this research to an 
existing human being takes precedence over the harm to a potential human 
being.123  
With the moral complexity of the embryo as a foundation, another 
argument is that researchers should invest their time—and the government 
its money—in stem cells from adult tissue instead of those from an 
embryo.124 In addition to the elimination of moral concerns,125 adult stem 
 
 
 120. Miller, supra note 8, at 852. The Catholic Church is among those who believe that an 
embryo, as well as a fetus, holds the moral status of a human being. Elisabeth Rosenthal, 
Excommunication Is Sought for Stem Cell Researchers, N.Y. TIMES, July 1, 2006, at A3. However, a 
Jewish scholar, considering a clinically created embryo a potential human life, notes that “a possible 
thing is not the same as the thing itself, and we treat each being relative to our duties at that time. We 
can agree, for example, that with utter certainty each of us will become a corpse, yet we do not treat 
one another as corpses.” Zoloth, supra note 6, at 143. See also ALLMAN, supra note 37, at 25 (noting 
that many scientists do not consider an embryo to be the beginning of a life until it has implanted itself 
in the womb since that is the first time the embryo begins to differentiate into an organism, and as 
many as three of every four embryos die without implanting themselves). 
 121. See Andrew Sullivan, Only Human, THE NEW REPUBLIC, July 30, 2001, at 8 (comparing the 
moral status of embryos to that of fingernail clippings). President Bush has said that he does not 
consider the destruction of an embryo to be murder. Bush Spokesman Retracts Stem Cell Comment, 
N.Y. TIMES, July 25, 2006, at A16. If embryo destruction were considered murder, privately funded 
research would be prohibited and criminal sanctions would be in place. MONITORING, supra note 1, at 
26 (“At the federal level, research that involves the destruction of embryos is neither prohibited nor 
supported and encouraged.”). Therefore, since not prohibited, killing an embryo is not illegal under 
United States federal law. 
 122. See HUMAN CLONING AND HUMAN DIGNITY, supra note 2, at 152. In its report, the 
President’s Council on Bioethics asks, “Is destroying an embryo or cloned embryo at the blastocyst 
stage morally the same as killing a child? Is it the same as clipping a fingernail? Is it more like one of 
these acts than the other? Is it like neither?” Id.  
 123. See SCOTT, supra note 37, at 130.  
 124. See, e.g., Wade, supra note 11 (noting that Dr. Leon Kass, former chairman of the 
President’s Council on Bioethics, finds adult stem cells preferable to Dr. Lanza’s technique, which Dr. 
Kass called “inefficient.”). 
 125. MONITORING, supra note 1, at 10–11 (“Research involving adult stem cells raises few 
difficult ethical concerns, beyond the usual need to secure free and fully informed consent form donors 
and recipients, a favorable benefit-to-risk ratio for all participants in attempts at therapy, and 
protection of privacy. Adult stem cells are less controversial than embryonic ones, as we have noted, 
because the former can be collected without lasting harm to the donor.”); EVE HEROLD, STEM CELL 
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cell research is useful because “[i]mmune rejection could be avoided if 
one could use the patient’s own tissues.”126 However, adult stem cells do 
not show the promise that embryonic stem cells do.127 Recent discoveries 
suggest that adult stem cells might be as elastic as non-adult stem cells,128 
“[b]ut there are unanswered questions about the ease of culture and long-
term viability of such cells, and the likelihood of success with cellular 
models of disease derived from adult stem cells remains unknown.”129 
Moreover, while using a patient’s adult stem cells might help with 
immune rejection, patients who could benefit from stem cell therapy often 
cannot provide enough healthy tissue to be of use.130 
Other objections have been made which apply specifically to Dr. 
Lanza’s research. For example, some have asserted that the use of even 
one blastomere could mean the destruction of potential life.131 However, 
the President’s Council on Bioethics warns that “[p]ersons interested in 
the debate should note at the outset that [embryonic stem cells and 
embryonic germ cells] are not themselves embryos; they are not whole 
organisms, nor can they be made (directly) to become whole 
 
 
WARS: INSIDE STORIES FROM THE FRONTLINES 62 (2006) (noting that “there is no objection from any 
quarter to scientists pursuing research on adult stem cells”). 
 126. Kadereit & Hines, supra note 22, at 615. 
 127. Id. at 617 (“Embryonic stem cells are so attractive for research because they grow well in 
culture and retain the property of pluripotency during extended culture growth. Thus, after prolonged 
culture periods, embryonic stem cells can still produce a wide array of the cells of the body in culture. 
Embryonic stem cells provide, therefore, an unlimited supply of stem cells and specialized cells for 
meaningful experiments. Moreover, once the specifics have been worked out, these cells can give rise 
to clinically relevant cell numbers and could thus be used with greater ease in therapies than adult stem 
cells.”). 
 128. MONITORING, supra note 1, at 10. Non-adult stem cells include both embryonic and germ 
stem cells. See generally supra notes 31–39 and accompanying text. 
 129. HUMAN CLONING AND HUMAN DIGNITY, supra note 2, at 148. 
 130. Kadereit & Hines, supra note 22, at 615 (“[S]ome victims of severe burns do not have 
enough skin left to generate replacement tissue. Or, for patients with advanced degenerative diseases, 
most of the relevant tissue has already been destroyed. In addition, current observations suggest that 
adult stem cells age, and that the regenerative capacity of these cells decreases with increasing age. 
Thus, older patients may not be able to provide the cells necessary for their treatments.”). 
 131. Editorial, Stem Cells Without Embryo Loss, N.Y. TIMES, Aug. 26, 2006, at A14 (“[Lanza’s] 
approach won’t satisfy those who believe that even a single cell removed from an early embryo may 
have the potential to produce life.”); Rick Weiss, Stem Cells Created with No Harm to Human 
Embryos; But Concerns Are Raised About the Technique, WASH. POST, Aug. 24, 2006, at A03 (noting 
that some, including “Richard Doerflinger of the U.S. Conference of Catholic Bishops,” are concerned 
that one cell from an embryo could develop into another embryo); Wade, supra note 11 (quoting a 
spokesperson for Senator Sam Brownback as stating that developing a blastomere into a stem cell line 
is the equivalent of “‘creating a twin and then killing that twin.’”). 
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organisms.”132 Scientists have been unsuccessful in coaxing “a single cell 
taken from an eight-cell embryo” into becoming an embryo itself.133  
A final relevant argument concerns the health of the children who 
develop from these seven-cell embryos following pre-implantation genetic 
diagnosis (PGD).134 Estimates for the number of children born using the 
technique have exceeded 2000.135 Though more time and study is needed 
to ensure the method’s safety, babies born using PGD do not appear to be 
at greater risk than in vitro babies born without the procedure.136 
III. ANALYSIS 
President Bush’s 2001 policy identifies the problem in this area by 
what it aims to rectify: the clash of moral sentiment and desire for medical 
progress.137 It is a problem of weighing the harm to a potential life versus 
the potential benefit to an existing life. To benefit the scientific 
community through federal funding, Dr. Lanza’s method must comply 
with both the Dickey Amendment and President Bush’s 2001 policy. To 
resolve the embedded problem, Dr. Lanza’s method must overcome moral 
objections. Whether the method can overcome these obstacles may depend 
on the current state of medical evidence. 
 
 
 132. MONITORING, supra note 1, at 4. 
 133. Weiss, supra note 131 (“Experiments have shown that some mammals can develop from a 
single cell taken from a four-cell embryo. But several scientists yesterday said no mammal has ever 
been grown from a single cell taken from an eight-cell embryo—a more advanced stage of 
development in which each cell has already become somewhat specialized.”). But see ALLMAN, supra 
note 37, at 24–26 (explaining that through the eight-cell stage, embryonic stem cells remain 
totipotent—“capable of giving rise to every cell needed to grow an embryo, a fetus, and then a 
person”—but by the next division to sixteen cells, totipotency yields to pluripotency, meaning the stem 
cells could still form any cells of the body but “cannot form all the cells necessary to create a new life, 
such as those that give rise to the placenta”). 
 134. REPRODUCTION & RESPONSIBILITY, supra note 42, at 94 (positing the possibility of danger 
that removing a blastomere from a young embryo could pose to the resulting human being and noting 
the lack of information available). 
 135. Wade, supra note 11 (“Dr. Andrew La Barbera, scientific director of the American Society 
for Reproductive Medicine, said that more than 2,000 babies had been born in the United States after a 
preimplantation genetic diagnosis.”). 
 136. See infra note 160 and accompanying text. See also HEROLD, supra note 125, at 34 (“At such 
an early stage of existence, the process [of removing one cell for PGD] does not destroy the embryo; if 
implanted, it could still develop into a normal baby.”). 
 137. Bush, supra note 14, at 184 (asserting that his policy “allows us to explore the promise and 
potential of stem cell research without crossing a fundamental moral line”).  
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A. Does Dr. Lanza’s Method Conform to Current Legislation and Policy? 
President Bush’s 2001 policy was an attempt to reconcile the conflict 
of morality versus science.138 President Bush wanted to keep to the “spirit” 
of the Dickey Amendment while federally supporting stem cell 
research.139 Bush’s policy actually relied on the same interpretation of the 
Dickey Amendment that the Clinton Administration did, finding that the 
federal government could technically fund stem cell research which relied 
on an embryo’s destruction so long as the destruction occurred before 
federal funding came into play.140 This is a valid interpretation of the law 
as written,141 but President Bush only honored the amendment’s spirit to 
the extent that his policy discouraged further embryo destruction142 (or in 
the Dickey Amendment, also “risk of injury”).143 If the Dickey 
Amendment’s spirit is the protection of embryos, then President Bush’s 
policy could be said to violate that spirit to the extent that it rewards past 
embryo destruction. 
A method for embryonic stem cell research that would satisfy the 
stated aims of Bush’s 2001 policy, then, is one in which an embryo is 
neither put in harm’s way nor outright destroyed. Such a method would 
not only meet the aims and requirements of Bush’s policy,144 but because 
the method would never involve an embryo’s destruction at any stage of 
research, it would satisfy the “spirit”—and indeed precise requirements—
of the Dickey Amendment without creative interpretation. Though Dr. 
Lanza’s research in fact resulted in the destruction of all sixteen embryos, 
the technique which his study aimed to prove does not destroy the 
 
 
 138. Id. at 183 (“At its core, this issue forces us to confront fundamental questions about the 
beginnings of life and the ends of science. It lies at a difficult moral intersection, juxtaposing the need 
to protect life in all its phases with the prospect of saving and improving life in all its stages.”). 
 139. MONITORING, supra note 1, at 28. 
 140. Id. at 27. All seventy-eight stem cell lines eligible for federal funding resulted from the 
destruction of embryos. Press Release, The White House, Fact Sheet: Embryonic Stem Cell Research 
(Aug. 9, 2001), available at http://www.whitehouse.gov/news/releases/2001/08/20010809-1.html. 
Therefore, President Bush’s policy would have been precluded by the Dickey Amendment without 
Bush’s reliance on this interpretation. 
 141. See MONITORING, supra note 1, at 27. 
 142. Bush, supra note 14, at 184. 
 143. President Bush did not mention “risk of injury” along with “destruction” since the only 
known method of procuring embryonic stem cells at that time was via an embryo’s destruction. See 
Bush, supra note 14, at 182 (“Research on embryonic stem cells raises profound ethical questions, 
because extracting the stem cell destroys the embryo, and thus destroys its potential for life.”). Since 
the Dickey Amendment also mentions “risk of injury,” I will assume that President Bush’s aim also 
encompasses “risk of injury.” 
 144. See supra note 95 and accompanying text. 
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embryo.145 The question for Dr. Lanza’s method is therefore whether 
removing a blastomere presents potential harm to the eight-cell embryo. 
B. “Risk of Injury”146 to the Embryo and Resolution of Moral Issues 
The removal of blastomeres for diagnostic testing is a technique 
fertility clinics have employed for about ten years.147 Research shows that 
the tiny embryo recovers from the loss of a cell, and by all appearances, 
develops into a healthy baby.148  Yet unknown is what effects the early 
removal of a blastomere might have on long-term human development.149 
As of this writing, the oldest child created using PGD would be merely ten 
years old—hardly sufficient time for the scientific community to form 
conclusions as to PGD’s safety in the long term. Nevertheless, all evidence 
thus far points to the safety of PGD not only for the embryo150 but also for 
the resulting human being.151  
The Dickey Amendment and President Bush’s stem cell policy each 
refer to the embryo. Scientifically, the term embryo indicates “a certain 
stage of development.”152 The Dickey Amendment, however, more 
specifically and more broadly defines an embryo as “any organism, not 
protected as a human subject . . . , that is derived by fertilization, 
parthenogenesis, cloning, or any other means from one or more human 
gametes or human diploid cells.”153 An obvious legal question, then, is 
whether potential developmental harm to the resulting adult is legally 
relevant, since that adult would then be “protected as a human subject” 
and outside the parameters of the Dickey Amendment.154 Nevertheless, 
such harm would challenge the “spirit” of the amendment,155 with healthy 
development of the experimental embryo part of its goal.156 
 
 
 145. Weiss, supra note 55. 
 146. MONITORING, supra note 1, at 25–26 (quoting section 128 of Balanced Budget 
Downpayment Act, I, Pub. L. No. 104-99, 110 Stat. 26 (1996)). 
 147. Wade, supra note 11. 
 148. Id. 
 149. REPRODUCTION & RESPONSIBILITY, supra note 42, at 94. 
 150. SCOTT, supra note 37, at 120 (explaining that an “embryo recovers with a quick round of cell 
division” after having one of its eight cells removed for PGD). 
 151. See supra note 136 and accompanying text. 
 152. MONITORING, supra note 1, at 12; see also notes 118–19 and accompanying text. 
 153. Department of Health and Human Services Appropriations Act 2006, Pub. L. No. 109-149, § 
509, 119 Stat. 2833, 2280 (2005). 
 154. Id. 
 155. MONITORING, supra note 1, at 27. 
 156. As a mere rider to the annual appropriations bill, little legislative history exists to elucidate 
Congress’s intent for the Dickey Amendment. See supra note 67 and accompanying text. The “spirit” 
of the amendment seems to be the protection of nascent human life from government-funded 
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Another possible harm concerns not the remaining seven-cell embryo 
but the removed blastomere. If that single blastomere could develop into 
another embryo, then its use for the creation of a stem cell line could be 
seen as the destruction, or perhaps prevention, of an embryo. This would 
bring the moral dilemma full circle in that the experimental use of the 
blastomere might be viewed as the scientific harm of potential life. Again, 
the legal relevance of this concern is questionable since the blastomere, 
even if capable of becoming an embryo, is not technically an embryo at 
this point but merely a single-celled representative.157 The Dickey 
Amendment regulates the scientific use of embryos, not potential 
embryos.158 For now, however, the inquiry is moot. Scientists have been 
unsuccessful in coaxing a blastomere extracted from an eight-cell embryo 
into becoming an embryo.159 
C. State of Medical Evidence and Efficiency 
Dr. Lanza’s method requires more medical knowledge. To know 
whether or not PGD poses a developmental harm to the human beings 
created using this technique, time and study are needed.160 Additionally, 
since Dr. Lanza’s is the first experiment utilizing the PGD technique to 
culture stem cell lines, the scientific community requires replication of the 
study in order to verify that blastomeres removed through PGD can 
develop into stem cell lines.161  
More specific problems with Dr. Lanza’s study have been suggested. 
First, “the new method, if confined to blastomeres derived from PGD, 
would not provide a highly desired type of cell, those derived from 
patients with a specific disease.”162 However, disease-specific stem cell 
 
 
destruction and harm. See MONITORING, supra note 1, at 28. It therefore seems logical that this spirit 
would also entail the protection of actual human life from harm resulting from government-funded 
testing at the embryonic stage (e.g., the spirit would not condone embryonic experimentation to 
produce a living Cyclops). 
 157. THE AMERICAN HERITAGE DICTIONARY OF THE ENGLISH LANGUAGE, supra note 44. 
 158. See Department of Health and Human Services Appropriations Act 2006, Pub. L. No. 109-
149, § 509, 119 Stat. 2833, 2280 (2005). 
 159. See supra note 133. 
 160. Wade, supra note 11 (“Dr. Andrew La Barbera, scientific director of the American Society 
for Reproductive Medicine, said that more than 2,000 babies had been born in the United States after a 
preimplantation genetic diagnosis. There is no sign yet that they have any greater risk of disease than 
other in vitro fertilization babies, but the society needs more data to be sure, Dr. La Barbera said.”). 
 161. A Way Out?: Scientists Might Now Be Able to Harvest Stem Cells Without Harming 
Embryos, supra note 112. 
 162. Wade, supra note 11 (referencing Dr. Irving Weissman, a stem cell expert at Stanford 
University). 
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testing is already being done with little to no ethical controversy163 and 
without the help of Dr. Lanza’s research.164 Disease-specific cells are 
taken from patients who have the disease that scientists wish to study, so 
disease-specific cells are non-embryonic, or adult, stem cells.165 These 
cells are taken from the tissue of living humans, and the only real ethical 
issues concern the donor’s safety and consent.166  
Another problem is inefficiency, which no one has debated and which 
even Dr. Lanza admits.167 Only two of the ninety-one blastomeres cultured 
developed into stem cell lines.168 However, the government has made clear 
that the barriers to government funding for embryonic stem cell research 
exist because of moral, not efficiency, concerns.169  
Finally, Dr. Lanza cultured his stem cells using animal ingredients, 
which could entail potential problems for human use170 similar to those of 
mouse feeder cells in the current federally funded stem cell lines.171 Dr. 
Lanza is currently “developing non-animal nutrients” in order to solve this 
problem.172  
Dr. Lanza’s technique honors the “spirit” of the Dickey Amendment 
more so than President Bush’s stem cell policy does.173 All available 
medical evidence suggests that the PGD process poses no risk of injury to 
the remaining seven-celled embryo,174 and that the single cell removed for 
PGD could not itself become an embryo.175 The few problems that Dr. 
 
 
 163. See MONITORING, supra note 1, at 10. 
 164. Kadereit & Hines, supra note 22, at 621 (“For the most rapid progress towards human 
therapies, however, both types of stem cells, adult and embryonic, have to be investigated in more 
detail and in conjunction with one another. The strongest research in adult stem cells will be in concert 
with research in embryonic stem cells, and vice versa. Both types of stem cells have to be seen as one 
research field, consisting of two complementary entities.”).  
 165. See MONITORING, supra note 1, at 10. 
 166. Id. 
 167. Rick Weiss, New Method Makes Embryo-Safe Stem Cells, WASH. POST, Aug. 24, 2006, at A3 
(“The process is inefficient, Lanza acknowledged—and would probably be even more so if researchers 
were limited to taking just one cell per embryo.”).  
 168. Id. 
 169. The efficiency of research is something for scientists to worry about. The government’s only 
efficiency concern should be economic—whether or not its money is being spent efficiently. However, 
this economic concern in no way affects any moral considerations and should have no bearing on 
whether or not Dr. Lanza’s method receives federal funding. The United States government has 
created a precedent in directing millions of dollars toward less-promising adult stem cell research, 
choosing ethics over efficient spending. 
 170. Weiss, supra note 167. 
 171. See supra note 107 and accompanying text. 
 172. Weiss, supra note 167. 
 173. See supra notes 138–45 and accompanying text. 
 174. See supra notes 147–51 and accompanying text. 
 175. See supra note 133. 
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Lanza’s research now faces are to be expected with a new scientific 
technique, and public funding will help those problems to be resolved 
more rapidly.176 
IV. PROPOSAL 
Dr. Lanza’s technique should be monetarily endorsed by the federal 
government. President Bush’s 2001 policy sought to monetarily propel 
medical scientific advancement while honoring the “spirit” of the Dickey 
Amendment.177 Basically, Bush hoped to reconcile moral and scientific 
aims. Dr. Lanza seems to have achieved Bush’s goal better than Bush 
himself. Federal funding for Dr. Lanza’s technique would not encourage 
the destruction of or harm to embryos. Unlike Bush’s 2001 policy, though, 
funding Dr. Lanza’s technique would not require the past destruction of 
embryos, either. The “spirit” of the Dickey Amendment is to discourage 
future embryonic harm,178 but since the amendment never included a 
provision grandfathering past scientific research thenceforth forbidden, the 
spirit could also be said to include a refusal to reward prior unethical 
behavior. In this sense, the funding of Dr. Lanza’s research would go 
further than President Bush’s 2001 policy. Dr. Lanza’s technique not only 
encompasses the spirit of the Dickey Amendment but also conforms to the 
precise letter of the amendment without invoking creative interpretation.179 
Dr. Lanza’s technique for deriving embryonic stem cell lines should 
therefore be eligible for federal funding. 
Adult stem cells do not show the same promise that embryonic stem 
cells do in their potential for medical advancement.180 Nevertheless, adult 
stem cell research is not subject to any restrictions in order to be eligible 
for federal funding.181 The National Institutes of Health consistently 
provides significantly higher levels of funding to adult stem cell research 
than it does to human embryonic stem cell research.182 Admittedly, the 
 
 
 176. See supra note 23 and accompanying text. 
 177. MONITORING, supra note 1, at 28. 
 178. Id. at 27. 
 179. Id. (“If embryos were first destroyed by researchers supported by private funding, then 
subsequent research employing the derived embryonic stem cells, now propagated in tissue culture, 
might be considered eligible for federal funding.”). 
 180. See Kadereit & Hines, supra note 22, at 617. See also SCOTT, supra note 37 and 
accompanying text. 
 181. HEROLD, supra note 125, at 62. 
 182. SCOTT, supra note 37, at 171 (“In 2003, the NIH provided just $27 million for [human 
embryonic stem cell] research—only on the 20 or so approved lines—and 8 times that amount for 
research on adult stem cells.”); HEROLD, supra note 125, at 62 (“In 2005, the same year that the NIH 
invested over $607 million in stem cell research overall, research using human embryonic stem cells 
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only technique previously available for the derivation of embryonic stem 
cells183 was plagued by moral questions and debate, but Dr. Lanza’s 
technique of growing embryonic stem cell lines while sparing the embryos 
has largely alleviated those concerns. The United States government 
should not favor a less promising technology over a technology with 
largely moribund moral issues.  
The former federal concern involved weighing the potential benefit of 
embryonic stem cell research to existing life against the destruction or 
harm to potential life. Using Dr. Lanza’s technique, the embryo’s potential 
for development will not be extinguished, so the scale should tip in favor 
of the benefit to existing life. Dr. Lanza’s technique should acquire federal 
funding now since every second counts for those who can benefit.184 
V. CONCLUSION 
The controversy over Dr. Lanza’s research technique involves a 
significant moral component, but ultimately whether or not the research 
receives funding is a matter of law and policy, not morality. Sometimes 
these concepts attempt to coexist and sometimes not, but in a subject area 
in which one demographic can have so many different ideas of applied 
morality,185 morality and the law can never be in perfect harmony.  
In the case of stem cell research, law and policy were created 
specifically in the name of morality.186 Until now, the progress of medical 
science has confined embryonic stem cell research to obligatory embryo 
destruction,187 and as a result, policy has confined federally funded 
researchers to an inadequate number of sub-quality stem cell lines.188 Dr. 
Lanza’s technique preserves, by all known accounts, a healthy 
 
 
received only $39 million. In other words, the NIH spent about fourteen times as much on animal and 
adult stem cell research as it did on human embryonic stem cell research.”). 
 183. See supra notes 29–30 and accompanying text. 
 184. Miller, supra note 8, at 857–58. 
 185. Bush, supra note 14, at 181 (“The issue is debated within the church, with people of different 
faiths, even many of the same faith coming to different conclusions.”). 
 186. MONITORING, supra note 1, at 28 (“This is the ethical-legal logic of [President Bush’s 2001] 
stem cell funding policy: it seeks those benefits of embryonic stem cell research that might be 
attainable without encouraging or contributing to any future destruction of human embryos.”). 
 187. David P. Hamilton & Antonio Regalado, New Questions Emerge Over Stem-Cell Research 
Claims, WALL ST. J., Sept. 5, 2006, at A15. 
 188. Doerflinger, supra note 98, at 150 (“For, the limited number of cell lines that the Bush 
administration approved for federally funded research is, at best, adequate only for basic research to 
determine the most promising avenues for further exploration. The currently eligible cell lines are not 
only of insufficient volume for treatments, but they also have inadequate genetic diversity to treat most 
of the patients who may want cell implants; and they are grown in cultures of mouse feeder cells, 
which could make them inappropriate for human transplantation.”).  
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embryo189—all but eliminating moral concerns—and offers the possibility 
of myriad quality embryonic stem cell lines. The sooner the federal 
government grants funding for this technique, the sooner this possibility 
can be realized.190 
Elizabeth A. Holman∗
 
 
 189. A Way Out?: Scientists Might Now Be Able to Harvest Stem Cells Without Harming 
Embryos, supra note 112 (“The rest of the embryo can grow into a normal human child, according to 
all available scientific evidence.”). 
 190. Bush, supra note 14, at 182 (“Scientists further believe that rapid progress in [embryonic 
stem cell] research will come only with federal funds.”). This would, in fact, be the first time that 
quality embryonic stem cell lines were eligible for federal funding, since all of the currently eligible 
lines are contaminated with mouse feeder cells. See supra notes 16 and 107 and accompanying text. 
The problems with Dr. Lanza’s technique, such as efficiency, could also be solved more quickly with 
federal funding. See supra note 23 and accompanying text. 
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